Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-117182

NEOGENOMICS INC · NEO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Steven G. Brodie
Officer — Chief Scientific Officer
Period of report
Apr 20, 2016
Accepted (ET)
May 3, 2016 · 8:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———55,953D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F5$7.15Apr 20, 2016A100,000AApr 20, 2017Apr 20, 2021Common Stock100,000100,000D
Stock Option (Right to Buy)F1$1.69holding———Apr 12, 2012Apr 12, 2017Common Stock10,00010,000D
Stock Option (Right to Buy)F2$3.76holding———Apr 16, 2014Apr 16, 2018Common Stock10,00010,000D
Stock Option (Right to Buy)F3$3.45holding———Mar 5, 2015Mar 5, 2019Common Stock20,00020,000D
Stock Option (Right to Buy)F4$4.78holding———May 4, 2016May 4, 2020Common Stock120,000120,000D

Explanation of responses